Annual Statements Open main menu

NVE CORP /NEW/ - Quarter Report: 2021 December (Form 10-Q)

nvec20211231_10q.htm
 

Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

 

FORM 10-Q

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended   December 31, 2021

or

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                                    to                                     

 

Commission File Number: 000-12196

nve.jpg

NVE CORPORATION

(Exact name of registrant as specified in its charter)

 

Minnesota

 

41-1424202

(State or other jurisdiction of incorporation or organization)

 

(I.R.S. Employer Identification No.)

 

11409 Valley View Road, Eden Prairie, Minnesota

 

55344 

(Address of principal executive offices)

 

(Zip Code)

 

(952) 829-9217 

(Registrant’s telephone number, including area code)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

☒ Yes  ☐ No

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (Section 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

☒ Yes  ☐ No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐

Accelerated filer ☐

 

Non-accelerated filer ☒

Smaller reporting company ☒

  

Emerging growth company ☐ 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).     ☐ Yes  ☒ No

 

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading symbol(s)

Name of each exchange on which registered

Common Stock, $0.01 par value

NVEC

The NASDAQ Stock Market, LLC

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

Common Stock, $0.01 Par Value – 4,833,714 shares outstanding as of January 14, 2022

 

 

 

 

NVE CORPORATION

QUARTERLY REPORT ON FORM 10-Q

TABLE OF CONTENTS

 

PART I. FINANCIAL INFORMATION

 
   

Item 1. Financial Statements

 
   

Balance Sheets

 
   

Statements of Income for the Quarters Ended December 31, 2021 and 2020

 
   

Statements of Comprehensive Income for the Quarters Ended December 31, 2021 and 2020

 
   

Statements of Income for the Nine Months Ended December 31, 2021 and 2020

 
   

Statements of Comprehensive Income for the Nine Months Ended December 31, 2021 and 2020

 
   

Statements of Shareholders’ Equity for the Period Ended December 31, 2021

 
   

Statements of Shareholders’ Equity for the Period Ended December 31, 2020

 
   

Statements of Cash Flows

 
   

Notes to Financial Statements

 
   

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 
   

Item 4. Controls and Procedures

 
   

PART II. OTHER INFORMATION

 
   

Item 1. Legal Proceedings

 
   

Item 1A. Risk Factors

 
   

Item 4. Mine Safety Disclosures

 
   

Item 6. Exhibits

 
   

SIGNATURES

 
 

 

2

 

 

PART IFINANCIAL INFORMATION

 

Item 1. Financial Statements.

 

 

NVE CORPORATION

BALANCE SHEETS

  

(Unaudited)

December 31, 2021

  

March 31,

2021*

 

ASSETS

        

Current assets

        

Cash and cash equivalents

 $8,967,657  $10,427,340 

Marketable securities, short-term

  22,482,494   7,678,957 

Accounts receivable, net of allowance for uncollectible accounts of $15,000

  3,038,203   1,964,281 

Inventories

  4,367,675   3,900,777 

Prepaid expenses and other assets

  921,846   391,278 

Total current assets

  39,777,875   24,362,633 

Fixed assets

        

Machinery and equipment

  9,312,982   9,254,664 

Leasehold improvements

  1,810,872   1,810,872 
   11,123,854   11,065,536 

Less accumulated depreciation and amortization

  10,886,378   10,728,853 

Net fixed assets

  237,476   336,683 

Deferred tax assets

  260,134   73,538 

Marketable securities, long-term

  27,179,552   47,038,669 

Right-of-use asset – operating lease

  593,715   689,216 

Total assets

 $68,048,752  $72,500,739 
         

LIABILITIES AND SHAREHOLDERS’ EQUITY

        

Current liabilities

        

Accounts payable

 $111,243  $336,591 

Accrued payroll and other

  812,502   540,474 

Operating lease

  152,807   150,273 

Total current liabilities

  1,076,552   1,027,338 

Operating lease

  482,798   581,459 

Total liabilities

  1,559,350   1,608,797 
         

Shareholders’ equity

        

Common stock, $0.01 par value, 6,000,000 shares authorized; 4,833,714 issued and outstanding as of December 31, 2021 and 4,833,232 as of March 31, 2021

  48,337   48,332 

Additional paid-in capital

  19,411,158   19,338,127 

Accumulated other comprehensive income

  433,759   1,101,119 

Retained earnings

  46,596,148   50,404,364 

Total shareholders’ equity

  66,489,402   70,891,942 

Total liabilities and shareholders’ equity

 $68,048,752  $72,500,739 

 

*The March 31, 2021 Balance Sheet is derived from the audited financial statements contained in our Annual Report on Form 10-K for the fiscal year ended March 31, 2021.

 

See accompanying notes. 

 

3

 

 

NVE CORPORATION

STATEMENTS OF INCOME

(Unaudited)

 

  

Quarter Ended December 31

 
  

2021

  

2020

 

Revenue

        

Product sales

 $5,916,790  $6,332,349 

Contract research and development

  374,019   201,013 

Total revenue

  6,290,809   6,533,362 

Cost of sales

  1,385,006   1,075,048 

Gross profit

  4,905,803   5,458,314 

Expenses

        

Research and development

  596,492   702,216 

Selling, general, and administrative

  272,159   311,356 

Total expenses

  868,651   1,013,572 

Income from operations

  4,037,152   4,444,742 

Interest income

  283,940   365,498 

Income before taxes

  4,321,092   4,810,240 

Provision for income taxes

  855,685   884,531 

Net income

 $3,465,407  $3,925,709 

Net income per share – basic

 $0.72  $0.81 

Net income per share – diluted

 $0.72  $0.81 

Cash dividends declared per common share

 $1.00  $1.00 

Weighted average shares outstanding

        

Basic

  4,833,604   4,833,232 

Diluted

  4,835,770   4,833,261 

 

 

STATEMENTS OF COMPREHENSIVE INCOME

(Unaudited)

 

  

Quarter Ended December 31

 
  

2021

  

2020

 

Net income

 $3,465,407  $3,925,709 

Unrealized loss from marketable securities, net of tax

  (380,161)  (145,452)

Comprehensive income

 $3,085,246  $3,780,257 

 

See accompanying notes.

 

4

 

 

NVE CORPORATION

STATEMENTS OF INCOME

(Unaudited)

 

  

Nine Months Ended December 31

 
  

2021

  

2020

 

Revenue

        

Product sales

 $19,500,567  $14,850,157 

Contract research and development

  766,866   653,252 

Total revenue

  20,267,433   15,503,409 

Cost of sales

  4,698,720   2,852,757 

Gross profit

  15,568,713   12,650,652 

Expenses

        

Research and development

  2,112,630   2,399,164 

Selling, general, and administrative

  1,221,893   1,024,549 

Total expenses

  3,334,523   3,423,713 

Income from operations

  12,234,190   9,226,939 

Interest income

  868,519   1,166,102 

Income before taxes

  13,102,709   10,393,041 

Provision for income taxes

  2,411,228   1,833,127 

Net income

 $10,691,481  $8,559,914 

Net income per share – basic

 $2.21  $1.77 

Net income per share – diluted

 $2.21  $1.77 

Cash dividends declared per common share

 $3.00  $3.00 

Weighted average shares outstanding

        

Basic

  4,833,356   4,834,324 

Diluted

  4,835,781   4,834,411 

 

 

STATEMENTS OF COMPREHENSIVE INCOME

(Unaudited)

 

  

Nine Months Ended December 31

 
  

2021

  

2020

 

Net income

 $10,691,481  $8,559,914 

Unrealized (loss) gain from marketable securities, net of tax

  (667,361)  966,886 

Comprehensive income

 $10,024,120  $9,526,800 

 

See accompanying notes.

 

5

 

 

NVE CORPORATION

STATEMENTS OF SHAREHOLDERS EQUITY

(Unaudited)

 

              

Accumulated

         
          

Additional

  

Other

         
  

Common Stock

  

Paid-In

  

Comprehensive

  

Retained

     
  

Shares

  

Amount

  

Capital

  

Income

  

Earnings

  

Total

 

Balance as of March 31, 2021

  4,833,232  $48,332  $19,338,127  $1,101,119  $50,404,364  $70,891,942 

Comprehensive income:

                        

Unrealized loss on marketable securities, net of tax

              (90,165

)

      (90,165

)

Net income

                  3,579,566   3,579,566 

Total comprehensive income

                      3,489,401 

Stock-based compensation

          7,238           7,238 

Cash dividends declared ($1.00 per share of common stock)

                  (4,833,232

)

  (4,833,232

)

Balance as of June 30, 2021

  4,833,232   48,332   19,345,365   1,010,954   49,150,698   69,555,349 

Comprehensive income:

                        

Unrealized loss on marketable securities, net of tax

            (197,034)     (197,034)

Net income

               3,646,507   3,646,507 

Total comprehensive income

                  3,449,473 

Stock-based compensation

         56,999         56,999 

Cash dividends declared ($1.00 per share of common stock)

               (4,833,232)  (4,833,232)

Balance as of September 30, 2021

  4,833,232   48,332   19,402,364   813,920   47,963,973   68,228,589 
Exercise of stock options  482   5   (5)        

-

 
Comprehensive income:                        
Unrealized loss on marketable securities, net of tax            (380,161)     (380,161)
Net income               3,465,407   3,465,407 
Total comprehensive income                  3,085,246 
Stock-based compensation         8,799         8,799 
Cash dividends declared ($1.00 per share of common stock)               (4,833,232)  (4,833,232)
Balance as of December 31, 2021  4,833,714  $48,337  $19,411,158  $433,759  $46,596,148  $66,489,402 

 

See accompanying notes. 

 

6

 

 

NVE CORPORATION

STATEMENTS OF SHAREHOLDERS EQUITY

(Unaudited)

 

              

Accumulated

         
          

Additional

  

Other

         
  

Common Stock

  

Paid-In

  

Comprehensive

  

Retained

     
  

Shares

  

Amount

  

Capital

  

Income

  

Earnings

  

Total

 

Balance as of March 31, 2020

  4,835,038  $48,350  $19,383,956  $516,523  $58,046,520  $77,995,349 

Comprehensive income:

                        

Unrealized gain on marketable securities, net of tax

            1,242,662      1,242,662 

Net income

               2,411,865   2,411,865 

Total comprehensive income

                  3,654,527 

Stock-based compensation

         2,707         2,707 

Cash dividends declared ($1.00 per share of common stock)

               (4,835,038

)

  (4,835,038

)

Balance as of June 30, 2020

  4,835,038   48,350   19,386,663   1,759,185   55,623,347   76,817,545 

Repurchase of common stock

  (1,806

)

  (18

)

  (91,401

)

        (91,401

)

Comprehensive income:

                        

Unrealized loss on marketable securities, net of tax

            (130,324

)

      (130,324

)

Net income

               2,222,340   2,222,340 

Total comprehensive income

                      2,092,016 

Stock-based compensation

          34,315           34,315 

Cash dividends declared ($1.00 per share of common stock)

                  (4,835,038

)

  (4,835,038

)

Balance as of September 30, 2020

  4,833,232   48,332   19,329,577   1,628,861   53,010,649   74,017,419 
Comprehensive income:                        
Unrealized loss on marketable securities, net of tax            (145,452)     (145,452)
Net income               3,925,709   3,925,709 
Total comprehensive income                  3,780,257 
Stock-based compensation         4,275         4,275 
Cash dividends declared ($1.00 per share of common stock)               (4,833,232)  (4,833,232)
Balance as of December 31, 2020  4,833,232  $48,332  $19,333,852  $1,483,409  $52,103,126  $72,968,719 

 

See accompanying notes. 

 

7

 

 

NVE CORPORATION

STATEMENTS OF CASH FLOWS

(Unaudited)

 

  

Nine Months Ended December 31

 
  

2021

  

2020

 

OPERATING ACTIVITIES

        

Net income

 $10,691,481  $8,559,914 

Adjustments to reconcile net income to net cash provided by operating activities:

        

Depreciation and amortization

  358,828   386,968 

Stock-based compensation

  73,036   41,297 

Deferred income taxes

  319   (73,269)

Changes in operating assets and liabilities:

        

Accounts receivable

  (1,073,922)  (467,290)

Inventories

  (466,898)  41,973 

Prepaid expenses and other assets

  (435,067)  181,557 

Accounts payable and other liabilities

  (49,447)  (140,082)

Net cash provided by operating activities

  9,098,330   8,531,068 
         

INVESTING ACTIVITIES

       

Purchases of fixed assets

  (58,317) (13,627)

Proceeds from maturities of marketable securities

  4,000,000   12,000,000 

Cash provided by investing activities

  3,941,683   11,986,373 
         

FINANCING ACTIVITIES

        
Repurchase of common stock  -   (91,419)

Payment of dividends to shareholders

  (14,499,696)  (14,503,308)

Cash used in financing activities

  (14,499,696)  (14,594,727)

(Decrease) increase in cash and cash equivalents

  (1,459,683)  5,922,714 
         

Cash and cash equivalents at beginning of period

  10,427,340   8,065,594 
         

Cash and cash equivalents at end of period

 $8,967,657  $13,988,308 
         

Supplemental disclosures of cash flow information:

        

Cash paid during the period for income taxes

 $2,490,000  $1,636,788 

 

See accompanying notes. 

 

8

 

NVE CORPORATION

NOTES TO FINANCIAL STATEMENTS

(Unaudited)

 

 

NOTE 1. DESCRIPTION OF BUSINESS

 

We develop and sell devices that use spintronics, a nanotechnology that relies on electron spin rather than electron charge to acquire, store, and transmit information. 

 

 

NOTE 2. BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation

 

The accompanying unaudited financial statements of NVE Corporation are prepared consistent with accounting principles generally accepted in the United States and in accordance with Securities and Exchange Commission rules and regulations. In the opinion of management, these financial statements reflect all adjustments, consisting only of normal and recurring adjustments, necessary for a fair presentation of the financial statements. Although we believe that the disclosures are adequate to make the information presented not misleading, certain disclosures have been omitted as allowed, and it is suggested that these unaudited financial statements be read in conjunction with the audited financial statements and the notes included in our latest annual financial statements included in our Annual Report on Form 10-K for the fiscal year ended March 31, 2021. The results of operations for the quarter and nine months ended December 31, 2021 are not necessarily indicative of the results that may be expected for the full fiscal year ending March 31, 2022.

 

Significant accounting policies

 

A description of our significant accounting policies is provided in Note 2 to the Financial Statements in our Annual Report on Form 10-K for the year ended March 31, 2021. As of December 31, 2021, there were no changes to our significant accounting policies.

 

 

NOTE 3. RECENTLY ISSUED ACCOUNTING STANDARDS

 

Recently Adopted Accounting Standard

 

In December 2019, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2019-12, Income Taxes (Topic 740)—Simplifying the Accounting for Income Taxes. ASU 2019-12 simplifies accounting for income taxes, removes certain exceptions to the general principles in Topic 740, and amends existing guidance to improve consistent application. We adopted ASU 2019-12 beginning with the quarter ended June 30, 2021. The adoption had no material impact on our financial statements.
 

New Accounting Standard Not Yet Adopted

 

In May 2021, the FASB issued ASU No. 2021-04, Earnings Per Share (Topic 260), DebtModifications and Extinguishments (Subtopic 470-50), CompensationStock Compensation (Topic 718), and Derivatives and HedgingContracts in Entitys Own Equity (Subtopic 815-40) Issuers Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options. ASU 2021-04 addresses issuer’s accounting for certain modifications or exchanges of freestanding equity-classified written call options. ASU 2021-04 is effective for fiscal years beginning after December 15, 2021 and interim periods within those fiscal years, which is fiscal 2023 for us, with early adoption permitted. We do not expect adoption of the new guidance to have a significant impact on our financial statements.

 

 

NOTE 4. NET INCOME PER SHARE

 

Net income per basic share is computed based on the weighted-average number of common shares issued and outstanding during each period. Net income per diluted share amounts assume exercise of all stock options. The following tables show the components of diluted shares:

 

  

Quarter Ended December 31

 
  

2021

  

2020

 

Weighted average common shares outstanding – basic

  4,833,604   4,833,232 

Dilutive effect of stock options

  2,167   29 

Shares used in computing net income per share – diluted

  4,835,770   4,833,261 

 

  

Nine Months Ended December 31

 
  

2021

  

2020

 

Weighted average common shares outstanding – basic

  4,833,356   4,834,324 

Dilutive effect of stock options

  2,425   87 

Shares used in computing net income per share – diluted

  4,835,781   4,834,411 

 

9

 

NOTE 5. FAIR VALUE OF FINANCIAL INSTRUMENTS

 

Our corporate bonds and money market funds are classified as available-for-sale securities and carried at estimated fair value. Unrealized holding gains and losses are included in accumulated other comprehensive income (loss) in the statement of shareholders’ equity. Corporate bonds with remaining maturities less than one year are classified as short-term, and those with remaining maturities greater than one year are classified as long-term. We consider all highly-liquid investments with maturities of three months or less when purchased, including money market funds, to be cash equivalents. Gains and losses on marketable security transactions are reported on the specific-identification method.

 

Contractual maturities of available-for-sale securities as of December 31, 2021 are as follows: 

 

Total

  

<1 Year

  

1–3 Years

  

3–5 Years

 
$57,293,870  $30,114,318  $22,148,686  $5,030,866 

 

Total available-for-sale securities represented approximately 84% of our total assets. Marketable securities as of December 31, 2021 had remaining maturities between three weeks and 38 months.

 

Generally accepted accounting principles establish a framework for measuring fair value, provide a definition of fair value, and prescribe required disclosures about fair-value measurements. Generally accepted accounting principles define fair value as the price that would be received to sell an asset or paid to transfer a liability. Fair value is a market-based measurement that should be determined using assumptions that market participants would use in pricing an asset or liability. Generally accepted accounting principles utilize a valuation hierarchy for disclosure of fair value measurements. The categorization within the valuation hierarchy is based on the lowest level of input that is significant to the fair value measurement. The categories within the valuation hierarchy are described as follows:

 

Level 1 – Financial instruments with quoted prices in active markets for identical assets or liabilities.

 

Level 2 – Financial instruments with quoted prices in active markets for similar assets or liabilities. Level 2 fair value measurements are determined using either prices for similar instruments or inputs that are either directly or indirectly observable, such as interest rates.

 

Level 3 – Inputs to the fair value measurement are unobservable inputs or valuation techniques.

 

Money market funds are included on the balance sheets in “Cash and cash equivalents.” Corporate bonds are included on the balance sheets in “Marketable securities, short term” and “Marketable securities, long term.”

 

The following table shows the estimated fair value of assets that were accounted for at fair value on a recurring basis:

 

  

As of December 31, 2021

  

As of March 31, 2021

 
  

Level 1

  

Level 2

  

Total

  

Level 1

  

Level 2

  

Total

 

Money market funds

 $7,631,824  $-  $7,631,824  $10,143,196  $-  $10,143,196 

Corporate bonds

  -   49,662,046   49,662,046   -   54,717,626   54,717,626 

Total

 $7,631,824  $49,662,046  $57,293,870  $10,143,196  $54,717,626  $64,860,822 

 

Our available-for-sale securities as of December 31 and March 31, 2021, aggregated into classes of securities, were as follows:

 

  

As of December 31, 2021

  

As of March 31, 2021

 
  

Amortized

Cost

  

Gross

Unrealized

Holding

Gains

  

Gross

Unrealized

Holding

Losses

  

Estimated

Fair

Value

  

Amortized

Cost

  

Gross

Unrealized

Holding

Gains

  

Gross

Unrealized

Holding

Losses

  

Estimated

Fair

Value

 

Money market funds

 $7,631,824  $-  $-  $7,631,824  $10,143,196  $-  $-  $10,143,196 

Corporate bonds

  49,106,800   772,080   (216,834)  49,662,046   53,308,105   1,570,195   (160,674

)

  54,717,626 

Total

 $56,738,624  $772,080  $(216,834) $57,293,870  $63,451,301  $1,570,195  $(160,674

)

 $64,860,822 

 

10

 

The following table shows the gross unrealized holding losses and fair value of our available-for-sale securities with unrealized holding losses, aggregated by class of securities and length of time that individual securities had been in a continuous unrealized loss position as of December 31, 2021 and March 31, 2021.

 

  

Less Than 12 Months

  

12 Months or Greater

  

Total

 
  

Estimated

Fair

Value

  

Gross

Unrealized

Holding

Losses

  

Estimated

Fair

Value

  

Gross

Unrealized

Holding

Losses

  

Estimated

Fair

Value

  

Gross

Unrealized

Holding

Losses

 
                         

As of December 31, 2021

                        

Corporate bonds

 $10,167,905  $(216,834) $-  $-  $10,167,905  $(216,834)

Total

 $10,167,905  $(216,834) $-  $-  $10,167,905  $(216,834)
                         

As of March 31, 2021

                        

Corporate bonds

 $10,322,539  $(160,674

)

 $-  $-  $10,322,539  $(160,674

)

Total

 $10,322,539  $(160,674

)

 $-  $-  $10,322,539  $(160,674

)

 

We did not consider any of our available-for-sale securities to be impaired as of December 31, 2021. None of the securities were impaired at acquisition, and subsequent declines in fair value are not attributed to declines in credit quality. The effects of the COVID-19 pandemic, however, have degraded outlooks for some of our marketable securities’ issuers, which could lead to credit-quality downgrades in the future. When evaluating for impairment we assess indicators that include, but are not limited to, earnings performance, changes in underlying credit ratings, market conditions, bona fide offers to purchase or sell, and ability to hold until maturity. Because we believe it is more likely than not we will recover the cost basis of our investments, we did not consider any of our marketable securities to be impaired as of December 31, 2021.

 

NOTE 6. INVENTORIES

 

Inventories are shown in the following table:

 

  

December 31,

2021

  

March 31,

2021

 

Raw materials

 $784,004  $660,678 

Work in process

  2,812,910   2,220,723 

Finished goods

  770,760   1,019,376 

Total inventories

 $4,367,675  $3,900,777 

 

 

NOTE 7. STOCK-BASED COMPENSATION

 

Stock-based compensation expense was $8,799 for the third quarter of fiscal 2022, $4,275 for the third quarter of fiscal 2021, $73,036 for the first nine months of fiscal 2022, and $41,297 for the first nine months of fiscal 2021. We calculate the share-based compensation expense using the Black-Scholes standard option-pricing model. 

 

 

NOTE 8. INCOME TAXES

 

Deferred income taxes reflect the net tax effects of temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes.

 

We had no unrecognized tax benefits as of December 31, 2021, and we do not expect any significant unrecognized tax benefits within 12 months of the reporting date. We recognize interest and penalties related to income tax matters in income tax expense. As of December 31, 2021 we had no accrued interest related to uncertain tax positions. The tax years 2016 through 2020 remain open to examination by the major taxing jurisdictions to which we are subject. 

 

11

 
 
 

NOTE 9. LEASES

 

We conduct our operations in a leased facility under a non-cancellable lease expiring March 31, 2026. Our lease does not provide an implicit rate, so we used our incremental borrowing rate to determine the present value of lease payments. Lease expense is recognized on a straight-line basis over the lease term. Variable lease costs consist primarily of common area maintenance and real estate taxes which are paid based on actual costs incurred by the lessor. Details of our operating lease are as follows: 

 

  Quarter Ended
Dec. 31, 2021
  Nine Months Ended
Dec. 31, 2021
 
Operating lease cost $42,516  $127,546 
Variable lease cost  31,029   93,087 
Total $73,545  $220,633 
         
Cash paid for amounts included in the measurement of lease liabilities        
Operating cash flows for leases
 $37,962  $113,886 
Remaining lease term 51 months     
Discount rate  3.5%    

 

 The following table presents the maturities of lease liabilities as of December 31, 2021:

 

Year Ending March 31 Operating Leases 
2022  38,817 
2023  156,121 
2024  159,592 
2025  163,224 
2026  165,947 
Total lease payments  683,701 
Imputed lease interest  (48,096)
Total lease liabilities $635,605 

 

 

NOTE 10. STOCK REPURCHASE PROGRAM

 

On January 21, 2009 we announced that our Board of Directors authorized the repurchase of up to $2,500,000 of our Common Stock from time to time in open market, block, or privately negotiated transactions. The timing and extent of any repurchases depends on market conditions, the trading price of the company’s stock, and other factors, and subject to the restrictions relating to volume, price, and timing under applicable law. On August 27, 2015, we announced that our Board of Directors authorized up to $5,000,000 of additional repurchases. Our repurchase program does not have an expiration date and does not obligate us to purchase any shares. The Program may be modified or discontinued at any time without notice. We intend to finance any stock repurchases with cash provided by operating activities or maturating marketable securities. The remaining authorization was $3,762,040 as of December 31, 2021. We have not repurchased any of our Common Stock during fiscal 2022. 

 

 

NOTE 11. INFORMATION AS TO EMPLOYEE STOCK PURCHASE, SAVINGS, AND SIMILAR PLANS

 

All of our employees are eligible to participate in our 401(k) savings plan the first quarter after reaching age 21. Employees may contribute up to the Internal Revenue Code maximum. We make matching contributions of 100% of the first 3% of participants’ salary deferral contributions. Our matching contributions were $21,579 for the third quarter of fiscal 2022, $22,571 for the third quarter of fiscal 2021, $76,995 for the first nine months of fiscal 2022, and $69,227 for the first nine months of fiscal 2021.

 

 

NOTE 12. SUBSEQUENT EVENTS

 

On January 19, 2022 we announced that our Board had declared a quarterly cash dividend of $1.00 per share of Common Stock to be paid February 28, 2022 to shareholders of record as of the close of business January 31, 2022.

 

12

 
 
 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

Forward-looking statements

 

Some of the statements made in this Report or in the documents incorporated by reference in this Report and in other materials filed or to be filed by us with the Securities and Exchange Commission (“SEC”) as well as information included in verbal or written statements made by us constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are subject to the safe harbor provisions of the reform act. Forward-looking statements may be identified by the use of the terminology such as may, will, expect, anticipate, intend, believe, estimate, should, or continue, or the negatives of these terms or other variations on these words or comparable terminology. To the extent that this Report contains forward-looking statements regarding the financial condition, operating results, business prospects or any other aspect of NVE, you should be aware that our actual financial condition, operating results and business performance may differ materially from that projected or estimated by us in the forward-looking statements. We have attempted to identify, in context, some of the factors that we currently believe may cause actual future experience and results to differ from their current expectations. These differences may be caused by a variety of factors, including but not limited to risks related to our reliance on several large customers for a significant percentage of revenue, our dependence on critical suppliers and packaging vendors, uncertainties related to the economic environments in the industries we serve, uncertainties related to future sales and revenues, risks and uncertainties related to future stock repurchases and dividend payments, and other specific risks that may be alluded to in this Report or in the documents incorporated by reference in this Report.

 

Further information regarding our risks and uncertainties are contained in Part I, Item 1A “Risk Factors” of our Annual Report on Form 10-K for the year ended March 31, 2021 as updated in Item 1A of this report.

 

General

 

NVE Corporation, referred to as NVE, we, us, or our, develops and sells devices that use spintronics, a nanotechnology that relies on electron spin rather than electron charge to acquire, store and transmit information. We manufacture high-performance spintronic products including sensors and couplers that are used to acquire and transmit data.

 

Critical accounting policies

 

A description of our critical accounting policies is provided in Management’s Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K for the year ended March 31, 2021. As of December 31, 2021 our critical accounting policies and estimates continued to include investment valuation, inventory valuation, and deferred tax assets estimation.

 

13

 

Quarter ended December 31, 2021 compared to quarter ended December 31, 2020

 

The table shown below summarizes the percentage of revenue and quarter-to-quarter changes for various items:

 

   

Percentage of Revenue

Quarter Ended December 31

   

Quarter-

to-Quarter

 
   

2021

   

2020

   

Change

 

Revenue

                       

Product sales

     94.1

%

    96.9

%

     (6.6)

%

Contract research and development

     5.9

%

     3.1

%

     86.1

%

Total revenue

    100.0

%

    100.0

%

     (3.7)

%

Cost of sales

     22.0

%

     16.5

%

     28.8

%

Gross profit

     78.0

%

     83.5

%

     (10.1)

%

Expenses

                       

Research and development

     9.5

%

    10.7

%

     (15.1)

%

Selling, general, and administrative

     4.3

%

     4.8

%

     (12.6)

%

Total expenses

     13.8

%

     15.5

%

     (14.3)

%

Income from operations

     64.2

%

     68.0

%

     (9.2)

%

Interest income

     4.5

%

     5.6

%

     (22.3)

%

Income before taxes

     68.7

%

     73.6

%

     (10.2)

%

Provision for income taxes

     13.6

%

     13.5

%

     (3.3)

%

Net income

     55.1

%

    60.1

%

     (11.7)

%

 

Total revenue for the quarter ended December 31, 2021 (the third quarter of fiscal 2022) decreased 4% compared to the quarter ended December 31, 2020 (the third quarter of fiscal 2021). The decrease was due to a 7% decrease in product sales partially offset by an 86% increase in contract research and development revenue.

 

The decrease in product sales in the third quarter of fiscal 2022 from the prior-year quarter was primarily due to raw materials shortages and longer lead-times for critical materials and services. The increase in contract research and development revenue was due to new contracts.

 

Gross profit as a percentage of revenue decreased to 78% the third quarter of fiscal 2022 from 84% the third quarter of fiscal 2021 primarily due to revenue mix and increased costs.

 

Total expenses decreased 14% in the third quarter of fiscal 2022 compared to the third quarter of fiscal 2021 due to a 15% decrease in research and development expense and a 13% decrease in selling, general, and administrative expense. The decrease in research and development expense was primarily due to staffing changes and the completion of certain product development activities. The decrease in selling, general, and administrative expense was primarily due to staffing changes.

 

Interest income for the third quarter of fiscal 2022 decreased 22% due to a decrease in our available-for-sale securities and a decrease in the average interest rates on those securities.

 

The 12% decrease in net income in the third quarter of fiscal 2022 compared to the prior-year quarter was primarily due to decreased revenue, decreased gross margin, and decreased interest income partially offset by decreased expenses. 

 

14

 

Nine months ended December 31, 2021 compared to nine months ended December 31, 2020

 

The table shown below summarizes the percentage of revenue and quarter-to-quarter changes for various items:

 

   

Percentage of Revenue

Nine Months Ended December 31

   

Period-

to-Period

 
   

2021

   

2020

   

Change

 

Revenue

                       

Product sales

     96.2

%

    95.8

%

     31.3

%

Contract research and development

     3.8

%

     4.2

%

     17.4

%

Total revenue

    100.0

%

     100.0

%

     30.7

%

Cost of sales

     23.2

%

    18.4

%

     64.7

%

Gross profit

     76.8

%

    81.6

%

     23.1

%

Expenses

                       

Research and development

     10.4

%

    15.5

%

     (11.9)

%

Selling, general, and administrative

     6.0

%

     6.6 

%

     19.3

%

Total expenses

     16.4

%

     22.1

%

     (2.6)

%

Income from operations

     60.4

%

     59.5

%

     32.6

%

Interest income

     4.2

%

     7.5

%

     (25.5)

%

Income before taxes

    64.6

%

    67.0

%

     26.1

%

Provision for income taxes

     11.8

%

    11.8

%

     31.5

%

Net income

     52.8

%

    55.2

%

     24.9

%

 

Total revenue for the nine months ended December 31, 2021 increased 31% compared to the nine months ended December 31, 2020. The increase was due to a 31% increase in product sales and a 17% increase in contract research and development revenue.

 

The increase in product sales from the prior-year period was primarily due to increased purchases by existing customers, and sales increased in most of our markets and product lines. The increase in contract research and development revenue was due to new contracts.

 

Gross profit as a percentage of revenue decreased to 77% for the first nine months of fiscal 2022 from 82% for the first nine months of fiscal 2021 primarily due to revenue mix and increased costs.

 

Total expenses decreased 3% for the first nine months of fiscal 2022 compared to the first nine months of fiscal 2021 due to a 12% decrease in research and development expense, partially offset by a 19% increase in selling, general, and administrative expense. The decrease in research and development expense was primarily due to staffing changes and the completion of certain product development activities. The increase in selling, general, and administrative expense was primarily due to increased employee compensation expense.

 

Interest income for the first nine months of fiscal 2022 decreased 26% due to a decrease in our available-for-sale securities and a decrease in the average interest rates on those securities.

 

The 25% increase in net income in the first nine months of fiscal 2022 compared to the prior-year period was primarily due to an increase in product sales.

 

The Impact of the COVID-19 Pandemic

 

We believe the impact of the COVID-19 pandemic on customer demand was significantly less in the quarter and nine months ended December 31, 2021 compared to the prior-year periods. We believe the impact of the pandemic on our supply chain, however, was significantly more in the quarter and nine months ended December 31, 2021 than in the prior-year periods. The effects of the pandemic also increased labor and materials costs and expenses for the quarter and nine months ended December 31, 2021.

 

15

 

Liquidity and Capital Resources

 

Overview

 

Cash and cash equivalents were $8,967,657 as of December 31, 2021 compared to $10,427,340 as of March 31, 2021. The $1,459,683 decrease in cash and cash equivalents during first nine months of fiscal 2022 was due to $14,499,696 of cash used in financing activities partially offset by $9,098,330 in net cash provided by operating activities and $3,941,683 of cash provided by investing activities.

 

Operating Activities

 

Net cash provided by operating activities related to product sales and research and development contract revenue as our primary source of working capital for the current and prior year quarters. Net cash provided by operating activities was $9,098,330 for first nine months of fiscal 2022 and $8,531,068 for the first nine months of fiscal 2021.

 

Accounts receivable increased by $1,073,922 during first nine months of fiscal 2022 primarily due to the timing of sales to and payments from customers.

 

Prepaid expenses and other assets increased by $435,067 due to the timing of estimated tax payments.
 

Inventories increased $466,898 due primarily to our decisions to increase work in process in order to mitigate longer vendor lead-times.

 

Investing Activities

 

Cash provided by investing activities during the nine months ended December 31, 2021 consisted of $4,000,000 in proceeds from maturities of marketable securities, partially offset by $58,317 in capital expenditures. Capital expenditures can vary from quarter to quarter depending on our needs and equipment purchasing opportunities. We have ordered several pieces of production equipment to increase our capacity. Therefore, we currently expect significantly more capital expenditures during fiscal 2022 than the $62,727 we invested in fiscal 2021.

 

Financing Activities

 

Cash used in financing activities during the nine months ended December 31, 2021 consisted of $14,499,696 of cash dividends paid to shareholders. In addition to cash dividends to shareholders paid in first nine months of fiscal 2022, on January 19, 2022 we announced that our Board had declared a cash dividend of $1.00 per share of Common Stock, or $4,833,714 based on shares outstanding as of January 14, 2022, to be paid February 28, 2022. We plan to fund dividends through cash provided by operating activities and proceeds from maturities of marketable securities. All future dividends will be subject to Board approval and subject to the company’s results of operations, cash and marketable security balances, estimates of future cash requirements, and other factors the Board may deem relevant. Furthermore, dividends may be modified or discontinued at any time without notice.

 

We currently believe our working capital and cash generated from operations will be adequate for our needs at least for the next 12 months.

 

16

 

Item 4. Controls and Procedures.

 

Disclosure Controls and Procedures

 

Management, with the participation of the Chief Executive Officer and Principal Financial Officer, has performed an evaluation of our disclosure controls and procedures that are defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934 (the “Exchange Act”) as of the end of the period covered by this Report. This evaluation included consideration of the controls, processes, and procedures that are designed to ensure that information required to be disclosed by us in the reports we file under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Principal Financial Officer, as appropriate to allow timely decisions regarding required disclosure. Although there have been changes in personnel involved in our controls, processes, and procedures, our management concluded that, as of December 31, 2021, our disclosure controls and procedures were effective.

 

Changes in Internal Controls

 

During the quarter ended December 31, 2021, there was no change in our internal control over financial reporting that materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

PART IIOTHER INFORMATION

 

Item 1. Legal Proceedings.

 

In the ordinary course of business we may become involved in litigation. At this time we are not aware of any material pending or threatened legal proceedings or other proceedings contemplated by governmental authorities that we expect would have a material adverse impact on our future results of operation and financial condition.

 

Item 1A. Risk Factors.

 

There have been no material changes from the risk factors disclosed in our Annual Report on Form 10-K for the fiscal year ended March 31, 2021 as updated in our Quarterly Report on Form 10-Q for the quarters ended June 30, 2021 and September 30, 2021.

 

Item 4. Mine Safety Disclosures.


None.
 

17

 

Item 6. Exhibits. 

 

Exhibit #

Description

31

Certification by Daniel A. Baker pursuant to Rule 13a-14(a)/15d-14(a).

   

32

Certification by Daniel A. Baker pursuant to 18 U.S.C. Section 1350.

   

101.INS

Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document)

   

101.SCH     

Inline XBRL Taxonomy Extension Schema Document

   

101.CAL

Inline XBRL Taxonomy Extension Calculation Linkbase Document

   

101.DEF

Inline XBRL Taxonomy Extension Definition Linkbase Document

   

101.LAB

Inline XBRL Taxonomy Extension Label Linkbase Document

   

101.PRE

Inline XBRL Taxonomy Extension Presentation Linkbase Document

   

104

Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

 

18

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

   

NVE CORPORATION

 
   

 (Registrant)

 
   
   

January 19, 2022

 

/s/ DANIEL A. BAKER 

 

Date

 

Daniel A. Baker

 
   

President, Chief Executive Officer,
and Principal Financial Officer

 
   
   
       
       
       

 

19